About us
Our team
Our science
Radiopharmaceuticals
Our technology
Abstracts & publications
Our pipeline
News
All news
ASX releases
Media releases
Events and presentations
Investors
Share price
Annual reports
Shareholder newsletter
Analyst coverage
Corporate governance
Corporate policies
Contact us
About us
Our team
Our science
Radiopharmaceuticals
Our technology
Abstracts & publications
Our pipeline
News
All news
ASX releases
Media releases
Events and presentations
Investors
Share price
Shareholder newsletter
Analyst coverage
Corporate governance
Corporate policies
Contact us
News
ASX Releases
August 24, 2023
TerThera Terbium-161 isotope supply agreement expanded
Read more
Read more
August 18, 2023
EGM Presentation
Read more
Read more
August 18, 2023
EGM Results
Read more
Read more
July 24, 2023
Dr Sherin Al-Safadi Appointed as Vice President Medical and Corporate Affairs
Read more
Read more
June 13, 2023
Pivalate Educational Webinar 14 June 2023
Read more
Read more
May 29, 2023
FDA Pre-IND Meeting Supports an IND Application for RAD101
Read more
Read more
Load More
MEDIA releases
December 1, 2022
GenesisCare and RAD Partner to Bring World First Novel Radiopharmaceuticals to Australian Cancer Patients
Read more
Read more
October 6, 2022
CEO Interview series with Wholesale Investor
Read more
Read more
July 8, 2022
RAD to Start Prostate Cancer Trial, Interview with Financial News Network
Read more
Read more
June 28, 2022
World Congress Trivehexin Poster Presentation Shows Encouraging Integrin Data
Read more
Read more
May 18, 2022
CEO Riccardo Canevari Updates Investors and Discusses Licensing of a Asset from UCLA
Read more
Read more
May 9, 2022
Radiopharm Theranostics panel discusses latest progress and understanding of the radiopharmaceutical sector
Read more
Read more
Previous
Load more
Events and Presentations
July 31, 2023
Company Presentation July 2023
Read more
Read more
Sign up to our mailing list.
Receive all the latest news from Radiopharm Theranostics.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form. Please fill out all starred fields.